Healthtech Startups

Veradigm provides solutions for healthcare stakeholders including payers, providers, and life science companies, leveraging its provider network to deliver data insights and research acceleration capabilities. The company operates within the healthcare ecosystem to improve patient access and enable clinical research.

3 investors

St. Louis medical device maker of the SPiN electromagnetic thoracic navigation platform for lung cancer diagnosis; acquired by Olympus in 2020.

3 investors

Veranex provides multi-disciplinary services to medical device and healthcare companies, supporting them from concept through commercialization of medical innovations. It positions itself as a partner to healthcare organizations across the medical product development process.

3 investors

Verdiva Bio is a biotechnology company focused on drug development. Its leadership brings experience in in-licensing, commercialization, and business development across the international biotech industry.

3 investors

Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement. The company operates in the medical device sector.

3 investors

3 investors

Vetsource provides digital prescription management and online pharmacy solutions for veterinary practices, enabling staff to streamline medication dispensing, manage client orders, and handle preventative care compliance through integrated workflows and branded e-commerce platforms.

3 investors

A company that builds interactive video experience (iVX) solutions designed to engage audiences and deliver measurable results for brands and agencies.

3 investors

Videra provides AI-powered technology that supports behavioral health clinicians by enhancing their capabilities and patient engagement to improve care delivery and outcomes. The platform serves behavioral health providers and healthcare systems, focusing on democratizing access to quality mental health care.

3 investors

ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment. The system is used by hospitals and cancer centers to treat pancreas, prostate, lung, liver, breast, and oligometastatic cancers.

3 investors

Vironexis is a clinical-stage biotechnology company developing gene therapies that deliver vectorized T-cell engagers in a single IV dose through its in-vivo protein engineering approach. It is building a pipeline of more than 10 product candidates aimed at providing durable, T-cell-mediated cancer treatments.

3 investors

Vista AI develops software that automates MRI image acquisition to enable clinicians to perform high-quality cardiac scans quickly and consistently. The company plans to expand its AI-driven technology to cover brain, prostate, spine, and other anatomical areas.

3 investors

VisusNano develops ophthalmic drug delivery products, focusing on treatments for ocular and eye diseases. The company combines expertise in drug delivery, ophthalmic surgery, and clinical trials to create products for eye-care patients.

3 investors

ViTAA offers the AiORTA Suite, a cloud-based platform that uses explainable AI to analyze CT scans and map the strength and weakness of aortic aneurysm tissue. It supports clinicians across the continuum of aortic aneurysm care, from diagnosis and surveillance to pre-operative planning and post-EVAR monitoring.

3 investors

3 investors

Vitarka Therapeutics develops ENDOPORE, a drug delivery technology designed to transport therapeutic molecules into cells to treat diseases including cancer. The company operates in the biotechnology sector, focusing on solving a key challenge in drug development by enabling treatment targets that previously could not be reached.

3 investors

VitVio builds Vetro, a surgical operations platform that uses 3D spatial intelligence and ambient sensing to track perioperative workflows in real time, automatically generate operative notes, identify surgical trays, and write data back to hospital EHR systems like Epic and Cerner. It serves hospitals and operating room teams to improve theatre efficiency, reduce clinician administrative burden, and recover hidden OR capacity.

3 investors

Viventium provides payroll and HR software specifically designed for healthcare providers, including solutions for staff hiring, retention, and labor compliance management.

3 investors

Vocality Health provides AI-powered voice translation for medical settings, enabling doctors to communicate directly with non-English-speaking patients without requiring human medical interpreters in hospitals and clinics.

3 investors

Vocca provides AI voice and text agents that handle patient phone calls, appointment booking, rescheduling, confirmations, and reminders for medical groups and practices. The product automates inbound and outbound call management around the clock and is built to meet healthcare compliance standards such as HIPAA, GDPR, and SOC2.

3 investors

Vocera offers the SmartHospital Platform, a system that connects hospital facilities from patient rooms to operating suites to coordinate clinical workflows. It is aimed at healthcare providers to support care delivery and resource management.

3 investors

Voi operates a behavioral health platform in the United States that uses artificial intelligence to flag imminent suicide risk. It is aimed at clinicians, hospitals and families, providing risk assessments for individuals and aggregate insights about patient populations to guide intervention.

3 investors

Voio develops AI tools for radiologists to enhance clinical care and patient outcomes in medical imaging. The company focuses on the healthcare industry where artificial intelligence applications remain underutilized.

3 investors

Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull. It targets chronic neurological disorders such as chronic subdural hematomas, neuropathic pain, and epilepsy in the medical device sector.

3 investors